V. Hernández-Gea

发表

Metabolomics as a diagnostic tool for idiopathic non‐cirrhotic portal hypertension

M. Martínez-Chantar, J. Lozano, A. Berzigotti, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury

K. Faber, S. Friedman, G. Gerken, 2017, Scientific Reports.

Mitochondria-targeted antioxidant mitoquinone deactivates human and rat HSC and reduces portal hypertension in cirrhotic rats

M. Murphy, R. Deulofeu, J. García‐Pagán, 2017 .

Pathogenesis of liver fibrosis.

S. Friedman, V. Hernández-Gea, 2011, Annual review of pathology.

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

Sandrine Imbeaud, Sergi Sayols, Manel Esteller, 2015, Hepatology.

Transfusion strategies for acute upper gastrointestinal bleeding.

M. Poca, V. Hernández-Gea, J. Gordillo, 2013, The New England journal of medicine.

Nontumoral portal vein thrombosis in patients awaiting liver transplantation

C. Fondevila, J. Fuster, J. García-Valdecasas, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Relative adrenal insufficiency in severe acute variceal and non‐variceal bleeding: influence on outcomes

E. Urgell, V. Hernández-Gea, C. Villanueva, 2015, Liver international : official journal of the International Association for the Study of the Liver.

The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2022, Life.

Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors.

R. Borrás, A. Berzigotti, J. García‐Pagán, 2021, Journal of hepatology.

Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.

S. Friedman, M. Czaja, R. Gordon, 2012, Gastroenterology.

Oncolytic immunotherapeutic virus in HCC: can it compete with molecular therapies?

J. Llovet, Clara Alsinet, V. Hernández-Gea, 2013, Journal of hepatology.

Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.

M. Ronot, V. Vilgrain, J. García‐Pagán, 2019, Journal of hepatology.

Idiopathic Portal Hypertension

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2018, Hepatology.

Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.

X. Forns, J. Calleja, J. García‐Pagán, 2020, Journal of hepatology.

Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.

X. Forns, J. Calleja, J. García‐Pagán, 2017, Gastroenterology.

Next generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.

D. Colomer, M. López-Guerra, J. García‐Pagán, 2020, Journal of hepatology.

Idiopathic Portal Hypertension (Portosinusoidal Disease)

J. García‐Pagán, V. Hernández-Gea, Á. García-Criado, 2018 .

Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding

M. Rudler, D. Thabut, N. Ganne-Carrié, 2021, Hepatology.

Portal Hypertensive Bleeding

J. García‐Pagán, V. Hernández-Gea, A. Cárdenas, 2019, Clinical Gastrointestinal Endoscopy.

Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study

V. de Lédinghen, A. de Gottardi, L. Rubbia‐Brandt, 2019, Hepatology.

Nonendoscopic management of acute esophageal variceal bleeding

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2017 .

Refractory Variceal Bleeding: When First Endoscopy Fails, What Next?

J. García‐Pagán, V. Hernández-Gea, F. Turon, 2017 .

Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis

D. Valla, J. Bosch, C. Bureau, 2016, Hepatology.

The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique

J. Bosch, J. García‐Pagán, F. Torres, 2015, Hepatology.

Clinical Evaluation and Prognosis

A. Berzigotti, V. Hernández-Gea, 2015, Digestive Diseases.

TIPS: Primary Therapy or Rescue in Treatment of Acute Variceal Hemorrhage

J. García‐Pagán, V. Hernández-Gea, F. Turon, 2014 .

Idiopathic portal hypertension: Natural history and long‐term outcome

A. Berzigotti, J. García‐Pagán, R. Miquel, 2014, Hepatology.

Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review

M. Poca, I. Gich, V. Hernández-Gea, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Development of Ascites in Compensated Cirrhosis With Severe Portal Hypertension Treated With β-Blockers

M. Poca, V. Hernández-Gea, J. Miñana, 2012, The American Journal of Gastroenterology.

Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.

V. Hernández-Gea, X. Torras, C. Guarner, 2009, Gastroenterology.

Variceal and other portal hypertension related bleeding.

J. García‐Pagán, V. Hernández-Gea, S. Casu, 2013, Best practice & research. Clinical gastroenterology.

Ischemic cholangiopathy: An update.

D. Valla, C. Lemaître, V. Hernández-Gea, 2020, Clinics and research in hepatology and gastroenterology.

Treatment of Acute Variceal Bleeding in 2021-When to Use Transjugular Intrahepatic Portosystemic Shunts?

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Clinics in liver disease.

Early rebleeding increases mortality of variecal bleeders on secondary prophylaxis with β-blockers and ligation.

M. Poca, V. Hernández-Gea, X. Torras, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Preemptive‐TIPS Improves Outcome in High‐Risk Variceal Bleeding: An Observational Study

M. Rudler, D. Thabut, F. Nevens, 2018, Hepatology.

Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury.

S. Friedman, J. García‐Pagán, J. Bosch, 2019, Journal of hepatology.

Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis

J. González-Navajas, F. Tomás-Barberán, J. García‐Pagán, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

Reduced hepatic stellate cell expression of kruppel‐like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury

S. Friedman, V. Hernández-Gea, Z. Ghiassi-Nejad, 2013, Hepatology.

Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

A. de Gottardi, D. Valla, C. Bureau, 2020, Clinics and research in hepatology and gastroenterology.

Drug induced liver injury and vascular liver disease.

D. Valla, C. Bureau, D. Larrey, 2020, Clinics and research in hepatology and gastroenterology.

The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

M. Avila, M. Ávila, J. Bosch, 2017, Hepatology.

Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

D. Valla, C. Bureau, E. de Raucourt, 2020, Clinics and research in hepatology and gastroenterology.

Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

V. Paradis, D. Valla, P. Bedossa, 2020, Clinics and research in hepatology and gastroenterology.

Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis.

A. de Gottardi, R. Salem, F. Leebeek, 2019, Journal of hepatology.

Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis.

D. Colomer, J. García‐Pagán, V. Hernández-Gea, 2015, Journal of hepatology.

Pharmacologic prevention of variceal bleeding and rebleeding

J. Bosch, V. Hernández-Gea, A. Baiges, 2018, Hepatology International.

Porto-sinusoidal vascular disease: proposal and description of a novel entity.

V. Vilgrain, A. de Gottardi, L. Rubbia‐Brandt, 2019, The lancet. Gastroenterology & hepatology.

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy

M. Trauner, P. Ferenci, P. Schwabl, 2019, Hepatology.

Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.

M. Rudler, D. Thabut, F. Nevens, 2021, Journal of hepatology.

The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery.

J. Fuster, J. García-Valdecasas, G. Martínez-Pallí, 2019, Journal of hepatology.

Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review

J. García‐Pagán, V. Hernández-Gea, M. Mandorfer, 2020, Seminars in Liver Disease.

Hepatic Venous Pressure Gradient Response in Non-Selective Beta-Blocker Treatment—Is It Worth Measuring?

J. García‐Pagán, V. Hernández-Gea, M. Mandorfer, 2019, Current Hepatology Reports.

Update on the management of gastric varices

Xuefeng Luo, V. Hernández-Gea, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Hepatocyte microvesicle levels improve prediction of mortality in patients with cirrhosis

V. Paradis, R. Moreau, D. Valla, 2018, Hepatology.

Acute variceal bleeding: risk stratification and management (including TIPS)

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2018, Hepatology International.

Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

L. Fuccio, J. García‐Pagán, Robyn Rosasco, 2022, Endoscopy.

Budd-Chiari Syndrome: Hepatic Venous Outflow Tract Obstruction

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Vascular Disorders of the Liver.

Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis

J. García‐Pagán, Arturo Pereira, V. Hernández-Gea, 2020, Annals of Hematology.

Congenital antithrombin deficiency in patients with splanchnic vein thrombosis

J. Corral, V. Vicente, J. García‐Pagán, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding

M. Rudler, D. Thabut, F. Nevens, 2022, Gut.

New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis

J. García‐Pagán, V. Hernández-Gea, M. Burrel, 2020, Seminars in Thrombosis and Hemostasis.

Portal cavernoma or chronic non cirrhotic extrahepatic portal vein obstruction.

D. Valla, C. Bureau, V. Hernández-Gea, 2020, Clinics and research in hepatology and gastroenterology.

Spermidine Supplementation Protects the Liver Endothelium from Liver Damage in Mice

S. Friedman, M. Coll, V. Hernández-Gea, 2021, Nutrients.

Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH

J. Thachil, V. Hernández-Gea, A. Tripodi, 2022, Journal of thrombosis and haemostasis : JTH.

The Pathophysiology of Portal Vein Thrombosis in Cirrhosis: Getting Deeper into Virchow’s Triad

V. Hernández-Gea, J. García-Pagán, L. Orts, 2022, Journal of clinical medicine.

Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study

F. Nevens, S. Sarin, D. Valla, 2020, Hepatology.

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension

H. Møller, H. Grønbaek, J. García‐Pagán, 2021, Frontiers in Physiology.

Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

M. Rudler, D. Thabut, F. Nevens, 2020, Journal of hepatology.

Non-invasive tests for clinically significant portal hypertension after HCV cure.

H. Yoshiji, X. Forns, E. Tsochatzis, 2022, Journal of hepatology.

Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis.

J. Trebicka, S. Kubicek, B. Hofer, 2022, Journal of hepatology.

Platelets arrive at the scene of fibrosis……studies.

S. Friedman, V. Hernández-Gea, 2011, Journal of hepatology.

END-STAGE LIVER DISEASE Bone marrow suppression Deteriorated liver function Portal hypertension TPO Splenic sequestration Plasma expansion Platelet production Platelet destruction Thrombocytopenia with platelets in liver FIBROGENESIS

S. Friedman, V. Hernández-Gea, 2011 .

Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis.

J. Bosch, Hélène Larrue, C. Bureau, 2022, Journal of hepatology.

Management of Liver Decompensation in Advanced Chronic Liver Disease: Ascites, Hyponatremia, and Gastroesophageal Variceal Bleeding

V. Hernández-Gea, A. Baiges, 2022, Clinical Drug Investigation.

Endoscopic hemostasis in acute esophageal variceal bleeding.

J. García‐Pagán, V. Hernández-Gea, A. Cárdenas, 2014, Gastroenterology clinics of North America.

A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis

M. Poca, V. Hernández-Gea, J. Miñana, 2017, Hepatology.

Sinusoidal obstruction syndrome.

V. de Lédinghen, M. Robin, D. Valla, 2020, Clinics and research in hepatology and gastroenterology.

Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH

J. Thachil, S. Stanworth, V. Hernández-Gea, 2021, Journal of thrombosis and haemostasis : JTH.

The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease

J. Thachil, S. Stanworth, V. Hernández-Gea, 2021, Journal of thrombosis and haemostasis : JTH.

Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH

J. Thachil, S. Stanworth, V. Hernández-Gea, 2022, Journal of thrombosis and haemostasis : JTH.

Social and medical support initiatives in vascular liver diseases in France, from child to adult.

V. Hernández-Gea, I. Ollivier-Hourmand, D. Debray, 2020, Clinics and research in hepatology and gastroenterology.

Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics

E. Gratacós, F. Crispi, M. Díaz-Ricart, 2021, Scientific Reports.

Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension.

J. Bosch, A. Berzigotti, J. García‐Pagán, 2015, Journal of hepatology.

Transjugular liver biopsy.

J. García‐Pagán, R. Miquel, V. Hernández-Gea, 2014, Clinics in liver disease.

Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data.

Zaibo Jiang, M. Rudler, D. Thabut, 2020, Gastroenterology.

Precision medicine in variceal bleeding: Are we there yet?

V. Hernández-Gea, A. Baiges, M. Magaz, 2020, Journal of hepatology.

Reply:

J. García‐Pagán, V. Hernández-Gea, 2019, Hepatology.

TIPS Indications and Contraindications—Pushing the Limits: Is Earlier Better?

V. Hernández-Gea, José Ferrusquía-Acosta, J. Ferrusquía-Acosta, 2019, Current Hepatology Reports.

Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

D. Valla, L. Savale, C. Bureau, 2020, Clinics and research in hepatology and gastroenterology.

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

J. Llovet, A. Villanueva, V. Hernández-Gea, 2013, Nature Reviews Gastroenterology &Hepatology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, A. Berzigotti, J. García‐Pagán, 2017 .

Baveno VII - Renewing consensus in portal hypertension.

H. Yoshiji, J. Fallowfield, V. Paradis, 2021, Journal of hepatology.

Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy.

S. Werner, S. Friedman, N. Nieto, 2013, Journal of hepatology.

Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

S. Friedman, J. Llovet, S. Toffanin, 2013, Gastroenterology.

Coexpression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular disease.

J. Lozano, J. García‐Pagán, S. Seijo, 2021, Journal of hepatology.

Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design

J. Llovet, V. Hernández-Gea, 2014, Clinical Cancer Research.

Unexpected disappearance of portal cavernoma on long-term anticoagulation.

J. García‐Pagán, V. Hernández-Gea, Á. García-Criado, 2014, Journal of hepatology.

Congenital Extrahepatic Portosystemic Shunts: Abernethy Malformation

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2021, Vascular Disorders of the Liver.

The Endothelium as a Driver of Liver Fibrosis and Regeneration

V. Hernández-Gea, Erica Lafoz, Maria Ruart, 2020, Cells.

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

C. Strassburg, D. Toth, J. Trebicka, 2020, Journal of hepatology.

Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.

D. Toth, J. Trebicka, W. Laleman, 2018, Gastroenterology.

Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C

X. Forns, M. Navasa, J. García‐Pagán, 2018, Hepatology.

The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study

J. García‐Pagán, V. Hernández-Gea, T. Lisman, 2022, Journal of thrombosis and haemostasis : JTH.

Impact of anticoagulation on upper‐gastrointestinal bleeding in cirrhosis. A retrospective multicenter study

M. Casas, J. García‐Pagán, J. Genescà, 2015, Hepatology.

Impact of SARS-CoV-2 Pandemic on Vascular Liver Diseases

J. García‐Pagán, V. Hernández-Gea, A. Albillos, 2021, Clinical Gastroenterology and Hepatology.

Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension.

A. Villanueva, A. Berzigotti, V. Hernández-Gea, 2013, World journal of gastroenterology.

Budd-Chiari syndrome.

V. Vilgrain, P. Potier, D. Valla, 2020, Clinics and research in hepatology and gastroenterology.

Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.

F. Nevens, R. Moreau, R. Jalan, 2016, Journal of hepatology.

Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis.

J. García‐Pagán, M. Senzolo, E. Reverter, 2020, Journal of hepatology.

Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis

J. Lozano, A. Berzigotti, C. Alonso, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Changes in HVPG predict hepatic decompensation in patients who achieved SVR to IFN-free therapy.

M. Trauner, P. Ferenci, P. Schwabl, 2019, Hepatology.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

A. de Gottardi, F. Nevens, J. Trebicka, 2022, Transplantation.

Reply to: "Underestimation of portal pressures by wedge hepatic venous pressures in patients with non-alcoholic steatohepatitis related cirrhosis- Possibilities and implications".

V. Hernández-Gea, L. Turco, J. Ferrusquía-Acosta, 2020, Journal of hepatology.

Genomics and proteomics in liver fibrosis and cirrhosis

S. Friedman, V. Hernández-Gea, Rebekka A. Hannivoort, 2012, Fibrogenesis & tissue repair.

Technical aspects of genomics and proteomics in chronic liver disease

S. Friedman, V. Hernández-Gea, Rebekka A. Hannivoort, 2012 .

Liver Fibrosis: What Is Reversible and What Not? How to Assess Regression?

V. Hernández-Gea, 2016 .

Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury

K. Faber, S. Friedman, G. Gerken, 2017, Scientific Reports.

J. García‐Pagán, V. Hernández-Gea, 2019, Hepatology.

Autophagy and mesenchymal cell fibrogenesis.

S. Friedman, V. Hernández-Gea, M. Hilscher, 2013, Biochimica et biophysica acta.

Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury.

J. Bosch, C. Peralta, J. García‐Pagán, 2017, Journal of hepatology.

Autophagy fuels tissue fibrogenesis

S. Friedman, V. Hernández-Gea, 2012, Autophagy.

Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease.

X. Forns, J. Trebicka, W. Laleman, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Autoimmune biomarkers in porto‐sinusoidal vascular disease: Potential role in its diagnosis and pathophysiology

M. Juan, J. García‐Pagán, S. Seijo, 2021, Liver international : official journal of the International Association for the Study of the Liver.

A simple nomogram identifies patients with refractory ascites with worse outcome after transjugular intrahepatic portosystemic shunt

J. García‐Pagán, V. Hernández-Gea, A. Albillos, 2021, European journal of gastroenterology & hepatology.

The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis

H. Møller, T. Sandahl, H. Grønbæk, 2016, Alimentary pharmacology & therapeutics.

Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis

M. Poca, J. Calleja, J. Lozano, 2023, Hepatology.

Portal vein thrombosis: yes or no on anticoagulation therapy.

J. García‐Pagán, V. Hernández-Gea, F. Turon, 2018, Current opinion in organ transplantation.

TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.

M. Rudler, D. Thabut, T. Sauerbruch, 2023, Journal of hepatology.

Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.

D. Valla, C. Bureau, A. Lebreton, 2020, Clinics and research in hepatology and gastroenterology.

Risk of non‐tumoural portal vein thrombosis in patients with HCV‐induced cirrhosis after sustained virological response

X. Forns, G. Casanovas, J. García‐Pagán, 2021, Liver international : official journal of the International Association for the Study of the Liver.

The ISTH SSC Subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration.

S. Stanworth, A. Gatt, V. Hernández-Gea, 2023, Journal of thrombosis and haemostasis : JTH.

Role of albumin treatment in patients with spontaneous bacterial peritonitis.

M. Poca, M. Casas, I. Gich, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

M. Rudler, D. Thabut, F. Nevens, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Rivaroxaban Reduces Portal Hypertension in Cirrhotic Rats by Deactivating Hepatic Stellate Cells and Reducing Intrahepatic Microthrombosis

M. Ávila, J. García‐Pagán, J. Bosch, 2016 .

Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.

J. García‐Pagán, J. Bosch, F. Torres, 2017, Gastroenterology.

Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

D. Valla, C. Bureau, E. de Raucourt, 2020, Clinics and research in hepatology and gastroenterology.

Letter: improve survival after variceal bleeding in cirrhosis—place pTIPS as early as possible after index bleed

M. Rudler, D. Thabut, J. García‐Pagán, 2023, Alimentary pharmacology & therapeutics.

Letter: improve survival! Place early pre-emptive TIPSS in high-risk variceal bleeders.

J. Trebicka, C. Bureau, H. Grønbæk, 2020, Alimentary pharmacology & therapeutics.

Preemptive TIPS in Child-Pugh C patients.

J. García‐Pagán, V. Hernández-Gea, 2019, Hepatology.

Practice makes better: TIPS procedures in referral centers

C. Bureau, V. Hernández-Gea, 2018, Hepatology.

[Early transjugular intrahepatic portosystemic shunt: When, how and in whom?].

J. García‐Pagán, V. Hernández-Gea, A. Baiges, 2016, Gastroenterologia y hepatologia.

Reply Letter 17‐2110.R2

J. García‐Pagán, V. Hernández-Gea, 2018 .

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

J. Ampuero, G. Casanovas, J. Genescà, 2023, Journal of Hepatology.

Mitochondria‐targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats

M. Murphy, R. Deulofeu, J. García‐Pagán, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Therapeutic targeting of adipose tissue macrophages ameliorates liver fibrosis in non-alcoholic fatty liver disease

Silvia Affò, P. Sancho-Bru, Delia Blaya, 2023, JHEP reports : innovation in hepatology.

Non‐invasive candidate protein signature predicts hepatic venous pressure gradient reduction in cirrhotic patients after sustained virologic response

F. Nigsch, X. Forns, C. Ukomadu, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Combination of MELD and lactate predicts death in patients treated with salvage TIPS for refractory variceal bleeding.

M. Rudler, D. Thabut, N. Ganne-Carrié, 2021, Hepatology.

The ISTH SSC subcommittee on Hemostatic Management of Patients with Liver Disease: goals, ambitions, and call for collaboration: reply.

S. Stanworth, A. Gatt, V. Hernández-Gea, 2023, Journal of thrombosis and haemostasis : JTH.

Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma.

S. Friedman, J. Llovet, S. Toffanin, 2013, Gastroenterology.

Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury.

S. Friedman, J. García‐Pagán, J. Bosch, 2019, Journal of hepatology.

Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.

S. Friedman, M. Czaja, R. Gordon, 2012, Gastroenterology.

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

M. Esteller, V. Mazzaferro, S. Imbeaud, 2015, Hepatology.

Transfusion strategies for acute upper gastrointestinal bleeding.

M. Poca, V. Hernández-Gea, J. Gordillo, 2013, The New England journal of medicine.

Liver: Can we identify failure to control acute variceal bleeding?

J. García‐Pagán, V. Hernández-Gea, 2014, Nature Reviews Gastroenterology &Hepatology.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, J. García‐Pagán, J. Genescà, 2017, Gastroenterologia y hepatologia.

MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up

J. García‐Pagán, S. Seijo, V. Hernández-Gea, 2023, Liver Cancer.

The genetics of portal hypertension: Recent developments and the road ahead.

V. Hernández-Gea, Luca Valenti, L. Ronzoni, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease

G. Sebastiani, Z. Younossi, V. Hernández-Gea, 2023, Nature reviews. Gastroenterology & hepatology.

Obeticholic acid: A new light in the shadows treating portal hypertension?

J. García‐Pagán, V. Hernández-Gea, J. Gracia‐Sancho, 2014, Hepatology.

AASLD Practice Guidance on the Use of TIPS, Variceal Embolization, and Retrograde Transvenous Obliteration in the Management of Variceal Hemorrhage.

Edward A. Lee, D. Thabut, S. Kalva, 2023, Hepatology.

Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis

M. Rudler, D. Thabut, G. Han, 2023, Hepatology.

A roadmap for clinical trials in MASH-related compensated cirrhosis.

Q. Anstee, V. Hernández-Gea, T. Reiberger, 2024, Nature reviews. Gastroenterology & hepatology.

Posters (Abstracts 289–2348)

D. Thabut, F. Nevens, M. Casas, 2019, Hepatology.